To screen ETFs by asset class, performance, yield and more, check out the
Using AVIIs RNA tech, they have the potential to tx even drug resistant TB. I hope officials in India know about
before it is too late.
Just curious, why do you never respond to anyone's questions? with all of your knowledge and insight, I would think you would be proud
I like your knowledge in the field, but it's useless if you do not respond to fellow investors. You get called out on the PUMP
Add a reply...
Latest StockTalks »
people get SRPT breaking news and analysis by email alert.
Get email alerts on SRPT »
Sarepta Therapeutics, Inc.
Get latest price
From other sites
Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
at Zacks.com (Jan 15, 2015)
10 Biotech Stories You Might've Missed This Week
at Benzinga.com (Jan 15, 2015)
Chimerix tackles Ebola outbreak
at CNBC.com (Jan 13, 2015)
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4
at Benzinga.com (Jan 13, 2015)
Sarepta Therapeutics Slumps: SRPT Falls 14.6% in Session - Tale of the Tape
at Zacks.com (Jan 13, 2015)
Xignite quote data
© 2015 Seeking Alpha